In vivo Retinal Fluorescence Imaging With Curcumin in an Alzheimer Mouse Model

Alzheimer’s disease (AD) is characterized by amyloid beta (Aβ) plaques in the brain detectable by highly invasive in vivo brain imaging or in post-mortem tissues. A non-invasive and inexpensive screening method is needed for early diagnosis of asymptomatic AD patients. The shared developmental origi...

Full description

Bibliographic Details
Main Authors: Ahmad Sidiqi, Daniel Wahl, Sieun Lee, Da Ma, Elliott To, Jing Cui, Eleanor To, Mirza Faisal Beg, Marinko Sarunic, Joanne A. Matsubara
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnins.2020.00713/full
_version_ 1818935765297528832
author Ahmad Sidiqi
Daniel Wahl
Sieun Lee
Sieun Lee
Da Ma
Elliott To
Jing Cui
Eleanor To
Mirza Faisal Beg
Marinko Sarunic
Joanne A. Matsubara
author_facet Ahmad Sidiqi
Daniel Wahl
Sieun Lee
Sieun Lee
Da Ma
Elliott To
Jing Cui
Eleanor To
Mirza Faisal Beg
Marinko Sarunic
Joanne A. Matsubara
author_sort Ahmad Sidiqi
collection DOAJ
description Alzheimer’s disease (AD) is characterized by amyloid beta (Aβ) plaques in the brain detectable by highly invasive in vivo brain imaging or in post-mortem tissues. A non-invasive and inexpensive screening method is needed for early diagnosis of asymptomatic AD patients. The shared developmental origin and similarities with the brain make the retina a suitable surrogate tissue to assess Aβ load in AD. Using curcumin, a FluoroProbe that binds to Aβ, we labeled and measured the retinal fluorescence in vivo and compared with the immunohistochemical measurements of the brain and retinal Aβ load in the APP/PS1 mouse model. In vivo retinal images were acquired every 2 months using custom fluorescence scanning laser ophthalmoscopy (fSLO) after tail vein injections of curcumin in individual mice followed longitudinally from ages 5 to 19 months. At the same time points, 1–2 mice from the same cohort were sacrificed and immunohistochemistry was performed on their brain and retinal tissues. Results demonstrated cortical and retinal Aβ immunoreactivity were significantly greater in Tg than WT groups. Age-related increase in retinal Aβ immunoreactivity was greater in Tg than WT groups. Retinal Aβ immunoreactivity was present in the inner retinal layers and consisted of small speck-like extracellular deposits and intracellular labeling in the cytoplasm of a subset of retinal ganglion cells. In vivo retinal fluorescence with curcumin injection was significantly greater in older mice (11–19 months) than younger mice (5–9 months) in both Tg and WT groups. In vivo retinal fluorescence with curcumin injection was significantly greater in Tg than WT in older mice (ages 11–19 months). Finally, and most importantly, the correlation between in vivo retinal fluorescence with curcumin injection and Aβ immunoreactivity in the cortex was stronger in Tg compared to WT groups. Our data reveal that retina and brain of APP/PS1 Tg mice increasingly express Aβ with age. In vivo retinal fluorescence with curcumin correlated strongly with cortical Aβ immunohistochemistry in Tg mice. These findings suggest that using in vivo fSLO imaging of AD-susceptible retina may be a useful, non-invasive method of detecting Aβ in the retina as a surrogate indicator of Aβ load in the brain.
first_indexed 2024-12-20T05:25:22Z
format Article
id doaj.art-c1c69abd5058410798feaa57763ea3be
institution Directory Open Access Journal
issn 1662-453X
language English
last_indexed 2024-12-20T05:25:22Z
publishDate 2020-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neuroscience
spelling doaj.art-c1c69abd5058410798feaa57763ea3be2022-12-21T19:51:54ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2020-07-011410.3389/fnins.2020.00713556271In vivo Retinal Fluorescence Imaging With Curcumin in an Alzheimer Mouse ModelAhmad Sidiqi0Daniel Wahl1Sieun Lee2Sieun Lee3Da Ma4Elliott To5Jing Cui6Eleanor To7Mirza Faisal Beg8Marinko Sarunic9Joanne A. Matsubara10Department of Ophthalmology & Visual Sciences, University of British Columbia, Vancouver, BC, CanadaSchool of Engineering Science, Simon Fraser University, Burnaby, BC, CanadaDepartment of Ophthalmology & Visual Sciences, University of British Columbia, Vancouver, BC, CanadaSchool of Engineering Science, Simon Fraser University, Burnaby, BC, CanadaSchool of Engineering Science, Simon Fraser University, Burnaby, BC, CanadaDepartment of Ophthalmology & Visual Sciences, University of British Columbia, Vancouver, BC, CanadaDepartment of Ophthalmology & Visual Sciences, University of British Columbia, Vancouver, BC, CanadaDepartment of Ophthalmology & Visual Sciences, University of British Columbia, Vancouver, BC, CanadaSchool of Engineering Science, Simon Fraser University, Burnaby, BC, CanadaSchool of Engineering Science, Simon Fraser University, Burnaby, BC, CanadaDepartment of Ophthalmology & Visual Sciences, University of British Columbia, Vancouver, BC, CanadaAlzheimer’s disease (AD) is characterized by amyloid beta (Aβ) plaques in the brain detectable by highly invasive in vivo brain imaging or in post-mortem tissues. A non-invasive and inexpensive screening method is needed for early diagnosis of asymptomatic AD patients. The shared developmental origin and similarities with the brain make the retina a suitable surrogate tissue to assess Aβ load in AD. Using curcumin, a FluoroProbe that binds to Aβ, we labeled and measured the retinal fluorescence in vivo and compared with the immunohistochemical measurements of the brain and retinal Aβ load in the APP/PS1 mouse model. In vivo retinal images were acquired every 2 months using custom fluorescence scanning laser ophthalmoscopy (fSLO) after tail vein injections of curcumin in individual mice followed longitudinally from ages 5 to 19 months. At the same time points, 1–2 mice from the same cohort were sacrificed and immunohistochemistry was performed on their brain and retinal tissues. Results demonstrated cortical and retinal Aβ immunoreactivity were significantly greater in Tg than WT groups. Age-related increase in retinal Aβ immunoreactivity was greater in Tg than WT groups. Retinal Aβ immunoreactivity was present in the inner retinal layers and consisted of small speck-like extracellular deposits and intracellular labeling in the cytoplasm of a subset of retinal ganglion cells. In vivo retinal fluorescence with curcumin injection was significantly greater in older mice (11–19 months) than younger mice (5–9 months) in both Tg and WT groups. In vivo retinal fluorescence with curcumin injection was significantly greater in Tg than WT in older mice (ages 11–19 months). Finally, and most importantly, the correlation between in vivo retinal fluorescence with curcumin injection and Aβ immunoreactivity in the cortex was stronger in Tg compared to WT groups. Our data reveal that retina and brain of APP/PS1 Tg mice increasingly express Aβ with age. In vivo retinal fluorescence with curcumin correlated strongly with cortical Aβ immunohistochemistry in Tg mice. These findings suggest that using in vivo fSLO imaging of AD-susceptible retina may be a useful, non-invasive method of detecting Aβ in the retina as a surrogate indicator of Aβ load in the brain.https://www.frontiersin.org/article/10.3389/fnins.2020.00713/fullamyloid betaplaquesAlzheimer’s DiseaseAPP/PS1fluorescencescanning laser ophthalmoscopy
spellingShingle Ahmad Sidiqi
Daniel Wahl
Sieun Lee
Sieun Lee
Da Ma
Elliott To
Jing Cui
Eleanor To
Mirza Faisal Beg
Marinko Sarunic
Joanne A. Matsubara
In vivo Retinal Fluorescence Imaging With Curcumin in an Alzheimer Mouse Model
Frontiers in Neuroscience
amyloid beta
plaques
Alzheimer’s Disease
APP/PS1
fluorescence
scanning laser ophthalmoscopy
title In vivo Retinal Fluorescence Imaging With Curcumin in an Alzheimer Mouse Model
title_full In vivo Retinal Fluorescence Imaging With Curcumin in an Alzheimer Mouse Model
title_fullStr In vivo Retinal Fluorescence Imaging With Curcumin in an Alzheimer Mouse Model
title_full_unstemmed In vivo Retinal Fluorescence Imaging With Curcumin in an Alzheimer Mouse Model
title_short In vivo Retinal Fluorescence Imaging With Curcumin in an Alzheimer Mouse Model
title_sort in vivo retinal fluorescence imaging with curcumin in an alzheimer mouse model
topic amyloid beta
plaques
Alzheimer’s Disease
APP/PS1
fluorescence
scanning laser ophthalmoscopy
url https://www.frontiersin.org/article/10.3389/fnins.2020.00713/full
work_keys_str_mv AT ahmadsidiqi invivoretinalfluorescenceimagingwithcurcumininanalzheimermousemodel
AT danielwahl invivoretinalfluorescenceimagingwithcurcumininanalzheimermousemodel
AT sieunlee invivoretinalfluorescenceimagingwithcurcumininanalzheimermousemodel
AT sieunlee invivoretinalfluorescenceimagingwithcurcumininanalzheimermousemodel
AT dama invivoretinalfluorescenceimagingwithcurcumininanalzheimermousemodel
AT elliottto invivoretinalfluorescenceimagingwithcurcumininanalzheimermousemodel
AT jingcui invivoretinalfluorescenceimagingwithcurcumininanalzheimermousemodel
AT eleanorto invivoretinalfluorescenceimagingwithcurcumininanalzheimermousemodel
AT mirzafaisalbeg invivoretinalfluorescenceimagingwithcurcumininanalzheimermousemodel
AT marinkosarunic invivoretinalfluorescenceimagingwithcurcumininanalzheimermousemodel
AT joanneamatsubara invivoretinalfluorescenceimagingwithcurcumininanalzheimermousemodel